Patents by Inventor Eric David Moher

Eric David Moher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of Treatment Using a Prodrug of an Excitatory Amino Acid
    Publication number: 20120172422
    Abstract: This invention relates to synthetic excitatory amino acid prodrugs and processes for their preparation. The invention further relates to methods of using, and pharmaceutical compositions comprising, the compounds for the treatment of neurological disorders and psychiatric disorders.
    Type: Application
    Filed: March 13, 2012
    Publication date: July 5, 2012
    Applicant: ELI LILLY AND COMPANY
    Inventors: Eric David Moher, James Allen Monn, Concepcion Pedregal-Tercero, Jaime Gonzalo Blanco-Urgoiti, Ivan Collado Cano
  • Methods of treatment using a prodrug of an excitatory amino acid
    Patent number: 8153683
    Abstract: This invention relates to synthetic excitatory amino acid prodrugs and processes for their preparation. The invention further relates to methods of using, and pharmaceutical compositions comprising, the compounds for the treatment of neurological disorders and psychiatric disorders.
    Type: Grant
    Filed: May 4, 2011
    Date of Patent: April 10, 2012
    Assignee: Eli Lilly and Company
    Inventors: Eric David Moher, James Allen Monn
  • METHODS OF TREATMENT USING A PRODRUG OF AN EXCITATORY AMINO ACID
    Publication number: 20110207672
    Abstract: This invention relates to synthetic excitatory amino acid prodrugs and processes for their preparation. The invention further relates to methods of using, and pharmaceutical compositions comprising, the compounds for the treatment of neurological disorders and psychiatric disorders.
    Type: Application
    Filed: May 4, 2011
    Publication date: August 25, 2011
    Applicant: ELI LILLY AND COMPANY
    Inventors: Eric David Moher, James Allen Monn, Concepcion Pedregal-Tercero, Jaime Gonzalo Blanco-Urgoiti, Ivan Collado Cano
  • Methods of treatment using a prodrug of an excitatory amino acid
    Patent number: 7964632
    Abstract: This invention relates to synthetic excitatory amino acid prodrugs and processes for their preparation. The invention further relates to methods of using, and pharmaceutical compositions comprising, the compounds for the treatment of neurological disorders and psychiatric disorders.
    Type: Grant
    Filed: January 15, 2010
    Date of Patent: June 21, 2011
    Assignee: Eli Lilly and Company
    Inventors: Eric David Moher, James Allen Monn, Concepcion Pedregal-Tercero, Ivan Collado Caño, Jaime Gonzalo Blanco-Urgoiti
  • PRODRUGS OF EXCITATORY AMINO ACIDS
    Publication number: 20100113579
    Abstract: This invention relates to synthetic excitatory amino acid prodrugs and processes for their preparation. The invention further relates to methods of using, and pharmaceutical compositions comprising, the compounds for the treatment of neurological disorders and psychiatric disorders.
    Type: Application
    Filed: January 15, 2010
    Publication date: May 6, 2010
    Applicant: ELI LILLY AND COMPANY
    Inventors: Eric David Moher, James Allen Monn, Concepcion Pedregal-Tercero, Jaime Gonzalo Blanco-Urgoiti, Ivan Collado Cano
  • Prodrugs of excitatory amino acids
    Patent number: 7671082
    Abstract: This invention relates to synthetic excitatory amino acid prodrugs and processes for their preparation. The invention further relates to methods of using, and pharmaceutical compositions comprising, the compounds for the treatment of neurological disorders and psychiatric disorders.
    Type: Grant
    Filed: March 31, 2008
    Date of Patent: March 2, 2010
    Assignee: Eli Lilly and Company
    Inventors: Eric David Moher, James Allen Monn
  • PRODRUGS OF EXCITATORY AMINO ACIDS
    Publication number: 20080182889
    Abstract: This invention relates to synthetic excitatory amino acid prodrugs and processes for their preparation. The invention further relates to methods of using, and pharmaceutical compositions comprising, the compounds for the treatment of neurological disorders and psychiatric disorders.
    Type: Application
    Filed: March 31, 2008
    Publication date: July 31, 2008
    Inventors: Eric David Moher, James Allen Monn, Concepcion Pedregal-Tercero, Jaime Gonzalo Blanco-Urgoiti, Ivan Collado Cano
  • Prodrugs of excitatory amino acids
    Patent number: 7371872
    Abstract: This invention relates to synthetic excitatory amino acid prodrugs and processes for their preparation. The invention further relates to methods of using, and pharmaceutical compositions comprising, the compounds for the treatment of neurological disorders and psychiatric disorders.
    Type: Grant
    Filed: June 6, 2003
    Date of Patent: May 13, 2008
    Assignee: Eli Lilly and Company
    Inventors: Eric David Moher, James Allen Monn
  • Process for resolving racemic mixtures of piperidine derivatives
    Publication number: 20040039206
    Abstract: A process for resolving a racemic mixture into its (R) and (S) enantiomers. The racemic mixture is reacted with a resolving agent selected from the group consisting of di-benzoyl-L-tartaric acid, di-benzoyl-D-tartaric acid, (S)-mandelic acid and (R)-mandelic acid in a solvent. The reaction is carried out under conditions sufficient to form soluble diastereomeric salts comprising the (R) enantiomer and the resolving agent, and the (S) enantiomer and the resolving agent, respectively. One of the diastereomeric salts is then isolated from the mixture. The free base of the isolated salt may then be generated in situ, and directly reacted with other compounds to synthesize useful chiral compounds.
    Type: Application
    Filed: April 30, 2003
    Publication date: February 26, 2004
    Inventors: Eric David Moher, Allie Edward Tripp
  • Process to prepare pharmaceutical compounds
    Patent number: 6252064
    Abstract: This invention provides a process for preparing diastereomerically pure cryptophycin compounds.
    Type: Grant
    Filed: March 31, 2000
    Date of Patent: June 26, 2001
    Assignees: Eli and Company, University of Hawaii, Wayne State University
    Inventors: Michael John Martinelli, Eric David Moher
  • Selective epoxidation process for preparing pharmaceutical compounds
    Patent number: 6143909
    Abstract: Cryptophycin compounds possessing a .beta.-epoxy moiety may be made with high stereoselectivity at various steps in the overall synthetic process. This invention also provides novel intermediates useful in preparing Cryptophycin compounds.
    Type: Grant
    Filed: August 24, 1999
    Date of Patent: November 7, 2000
    Assignee: Eli Lilly and Company
    Inventors: David Warren Hoard, Eric David Moher, Vinod Francis Patel, Bryan Hurst Norman